New Funding Opportunity from NIAID!

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases          Visit us on the Web New Funding Opportunity from NIAID! The NIAID Radiation/Nuclear Countermeasures Program (RNCP) supports extramural research to develop safe and effective radiation medical countermeasures and biodosimetry methods and/or devices for clinical use under emergency situations. We are pleased to present the following new funding opportunity: Radiation/Nuclear Medical Countermeasure Product Development Support (Solicitation Number: NIAID-DAIT-NIHAI201800019) The purpose of this contract is to advance the development of candidate medical countermeasures (MCMs), including biodosimetric approaches to determine radiation exposure. We anticipate that studies supported by this contract will advance candidate MCMs toward eventual FDA approval or licensure for acute radiation syndrome (ARS) or delayed effects of acute radiation exposure (DEARE). The response date for this solicitation is August 19, 2019. Visit FedBizOpps.gov for details about NIAID-DAIT-NIHAI201800019. Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107